Cabei notches $50m via “vaccine bond”

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Emerging Markets
EM LatAm

Cabei notches $50m via “vaccine bond”

Oliver West
November 12, 2020 07:00 AM
Mexico, camp, Matamoros, Covid-19, coronavirus, LatAm, 575
Matamoros, Mexico, 24 June 2020, doctors and a nurse are seen in the isolation area discussing the course of treatment for two unaccompanied minors who tested positive for coronavirus antibodies in the refugee camp. The antibody tests are not regarded as 100\% reliable and so the department of health later swabbed the patients to confirm the diagnosis. To date there have been no confirmed coronavirus patients in the camp, which is currently home to 1,500 people who are waiting for the asylum claims to be heard in the United States of America. | Lexie Harrison-Cripps/EMPICS Entertainment

The Central American Bank for Economic Integration (Cabei) said it became the first multilateral lender to sell a Covid-19 “vaccine bond” after raising $50m of five-year money to support immunisation initiatives when Covid-19 vaccine becomes available.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CoronavirusHondurasSSAHealth and BiotechAmericasLatAm BondsEmerging MarketsSupras and agenciesLatAmSRILatin America
OW
Oliver West
US Bureau Chief - Latin America Editor
Contact
Gift this article